Trials / Conditions / Obesity Type 2 Diabetes Mellitus

Obesity Type 2 Diabetes Mellitus

14 registered clinical trials studyying Obesity Type 2 Diabetes Mellitus — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Chinese, Overweight or Obesity, Real-World Registry Study NCT07525037	Chinese PLA General Hospital	—
Not Yet Recruiting	Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy NCT07518407	University of South Carolina	N/A
Not Yet Recruiting	Multicentric Approval Study Trans-Duodenal Barrier for Typ 2 Diabetes With Obesity NCT07417683	Trans-Duodenal Concepts GmbH	N/A
Recruiting	Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adu NCT07313384	University of South Carolina	—
Not Yet Recruiting	ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study NCT07336563	Jarosław Drobnik	—
Recruiting	Aleniglipron Phase 2 in Type 2 Diabetes Mellitus NCT07400588	Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	Phase 2
Not Yet Recruiting	CGM Use in Non-insulin Patients With DM2 NCT07128342	Milwaukee VA Medical Center	N/A
Active Not Recruiting	Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes NCT06712615	ProGen. Co., Ltd.	Phase 2
Completed	Triglyceride-Glucose and TGI-BMI Indices Compared With HOMA-IR NCT07260201	Hisar Intercontinental Hospital	—
Completed	Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Iraqi Patients With Type 2 Diabetes NCT07172269	Mais Qais Hbeeb	N/A
Completed	Safety and Tolerability Evaluationof Phascolarcobacterium Faecium NCT07285317	Spanish National Research Council	Phase 1
Completed	Impact Of Laparoscopic Sleeve Gastrectomy On Obesity-Related Comorbidities In Patients Over 65 Years NCT07437716	Kafrelsheikh University	N/A
Active Not Recruiting	Fat Around Heart Arteries as a Measure of Inflammation in Patients With Glycometabolic Disease NCT07144670	Odense University Hospital	—
Terminated	An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMI NCT00430742	Merck Sharp & Dohme LLC	Phase 3